Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon

[1]  R. Sartor,et al.  Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. , 2001, Gastroenterology.

[2]  R. Kiesslich,et al.  TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. , 2004, Immunity.

[3]  B. Jenkins,et al.  STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. , 2006, Gastroenterology.

[4]  Kenichi Matsubara,et al.  Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma , 2005, Oncogene.

[5]  Yuan‐Chang Chung,et al.  Serum interleukin‐6 levels reflect the disease status of colorectal cancer , 2003, Journal of surgical oncology.

[6]  A. Hoeflich,et al.  Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. , 2000, Cancer letters.

[7]  S. Akira,et al.  IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages , 2003, Nature Immunology.

[8]  P. Munkholm.  Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease , 2003, Alimentary pharmacology & therapeutics.

[9]  Sergio Wittlin,et al.  Differential hypermethylation of SOCS genes in ovarian and breast carcinomas , 2004, Oncogene.

[10]  D. Hilton,et al.  Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease. , 2002, Gastroenterology.

[11]  Carmen Z. Michaylira,et al.  Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. , 2004, Gastroenterology.

[12]  R. Dowling,et al.  Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. , 1993, Gastroenterology.

[13]  F. Sommerer,et al.  SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition , 2005, Oncogene.

[14]  Francesco Garaci,et al.  Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[15]  Stefan Wirtz,et al.  TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling , 2004 .

[16]  Stefano Landi,et al.  Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. , 2003, Cancer research.

[17]  L. Hennighausen,et al.  Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  I. Kawase,et al.  SOCS‐1 suppresses TNF‐α‐induced apoptosis through the regulation of Jak activation , 2004 .

[19]  I. Kawase,et al.  SOCS-1 suppresses TNF-alpha-induced apoptosis through the regulation of Jak activation. , 2004, International immunology.

[20]  B. Jenkins,et al.  Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice , 2002, Nature Medicine.

[21]  Kazuhiro Yoshida,et al.  Epigenetic inactivation of SOCS‐1 by CpG island hypermethylation in human gastric carcinoma , 2004, International journal of cancer.

[22]  R. Xavier,et al.  Colonic epithelial functional phenotype varies with type and phase of experimental colitis. , 2003, Gastroenterology.

[23]  D. Merlin,et al.  IL-6 Induces NF-κB Activation in the Intestinal Epithelia 1 , 2003, The Journal of Immunology.

[24]  S. Itzkowitz.  Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. , 2003, Journal of clinical gastroenterology.

[25]  Takafumi Yoshida,et al.  Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production , 2006, Oncogene.

[26]  M. Mareel,et al.  Disruption of STAT3 signaling leads to tumor cell invasion through alterations of homotypic cell–cell adhesion complexes , 2004, Oncogene.

[27]  鈴木 飛鳥.  CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation , 2001 .

[28]  Donald Metcalf,et al.  SOCS3 negatively regulates IL-6 signaling in vivo , 2003, Nature Immunology.

[29]  B. Jenkins,et al.  Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. , 2004, Gastroenterology.

[30]  Y. Maehara,et al.  Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. , 2006, Gastroenterology.

[31]  Seiya Kato,et al.  IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice , 2006, The Journal of experimental medicine.

[32]  P. Musiani,et al.  Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. , 2004, Cytokine.

[33]  D. Merlin,et al.  IL-6 induces NF-kappa B activation in the intestinal epithelia. , 2003, Journal of immunology.

[34]  J. Trosko,et al.  Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells. , 2004, Carcinogenesis.

[35]  R. Sartor,et al.  Suppressor of cytokine signaling-3 (SOCS-3) mRNA is preferentially induced during experimental enterocolitis, ulcerative colitis and Crohn's disease , 2000, Regulatory Peptides.

[36]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[37]  P. Heinrich,et al.  Expression of suppressors of cytokine signaling during liver regeneration. , 2001, The Journal of clinical investigation.

[38]  Biao He,et al.  SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.